BRAIDWELL LP 13D and 13G filings for Crinetics Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 4:06 pm Sale | 2023-12-31 | 13G | Crinetics Pharmaceuticals, Inc. CRNX | BRAIDWELL LP | 0 0.000% | -3,469,674 (Position Closed) | Filing |
| 2023-02-14 4:06 pm Purchase | 2022-12-31 | 13G | Crinetics Pharmaceuticals, Inc. CRNX | BRAIDWELL LP | 3,469,674 6.450% | 3,469,674 (New Position) | Filing |